Tag: cancer

ATLANTA -- Adults who are at high risk of becoming infected with the human immunodeficiency virus (HIV), which causes AIDS, ...

Lauren Sciences LLC, the private New York biotechnology company developing transformative V-Smart® Nanomedicines for brain diseases, today announced it was ...

ATLANTA -- A common single nucleotide polymorphism (SNP) was associated with increased risk for developing stroke in childhood survivors who ...

ATLANTA -- Maintenance treatment with the PARP inhibitor rucaparib (Rubraca) was well tolerated and provided clinical responses among patients with ...

ATLANTA -- Prostate cancer incidence and mortality rates are decreasing or stabilizing in most parts of the world, with the ...

ATLANTA -- Surgery was associated with higher survival rates for patients with HER2-positive (HER2+) stage 4 breast cancer compared with ...

Data presented in a news conference at AACR Annual Meeting ATLANTA - Switching pancreatic cancer patients to the PARP inhibitor ...

Credit: Sanford Burnham Prebys LA JOLLA, CALIF. - April 2, 2019 - The advent of immune checkpoint inhibitors--which "release the ...

ESMO Breast Cancer Congress, May 2-4, 2019, Berlin, GermanyCredit: © European Society for Medical Oncology Lugano, Switzerland, 2 April 2019 ...

Credit: Caltech Devising the best treatment for a patient with cancer requires doctors to know something about the traits of ...

ATLANTA -- The investigational anticancer therapeutic LOXO-195 (now known as BAY 2731954), which targets a family of proteins called TRKs, ...

Fate Therapeutics, in collaboration with UC San Diego researcher, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that ...

PITTSBURGH, April 1, 2019 - New research from the University of Pittsburgh School of Medicine and the UPMC Hillman Cancer ...

By identifying signature of 16 disease-related microbial species, this international study with Brazilian participation may contribute to develop predictive tests ...